Eva Giné Selected Research

Eva Giné Research Topics

Disease

16	Neoplasms (Cancer) 01/2024 - 12/2011
14	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 02/2006
13	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2024 - 09/2013
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2023 - 07/2014
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2023 - 02/2013
5	Lymphoma (Lymphomas) 06/2022 - 04/2005
4	Residual Neoplasm 10/2022 - 06/2006
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 07/2010
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2021
3	Multiple Myeloma 01/2021 - 05/2002
2	Infections 05/2024 - 01/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 06/2022 - 09/2013
1	Carcinogenesis 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Cytokine Release Syndrome 01/2021
1	Hemolysis 11/2020
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 11/2020
1	Disease Progression 01/2019
1	Shock 01/2018
1	Leukemia 03/2017
1	Hypersensitivity (Allergy) 10/2015
1	Ataxia (Dyssynergia) 11/2013
1	Monoclonal Gammopathy of Undetermined Significance 05/2002
1	Necrosis 05/2002

Drug/Important Bio-Agent (IBA)

11	Rituximab (Mabthera)FDA Link 10/2023 - 07/2010
3	ibrutinibIBA 05/2024 - 10/2022
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2020
3	Cyclin D1IBA 01/2021 - 09/2013
3	fludarabineIBA 01/2021 - 01/2008
2	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2021
2	Agammaglobulinaemia Tyrosine KinaseIBA 10/2022 - 11/2017
2	Cell-Free Nucleic AcidsIBA 06/2022 - 01/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 04/2005
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2008
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 05/2002
2	CytokinesIBA 01/2020 - 05/2002
2	daratumumabIBA 01/2020 - 03/2017
2	Inotuzumab OzogamicinIBA 01/2018 - 02/2013
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2008 - 01/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024
1	AntioxidantsIBA 01/2024
1	Bendamustine Hydrochloride FDA Link 10/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Long Noncoding RNAIBA 10/2023
1	B7-H1 AntigenIBA 01/2023
1	Serum AlbuminIBA 01/2022
1	CD40 Ligand (CD40L)IBA 12/2021
1	NucleosidesIBA 01/2021
1	CyclinsIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020
1	A-Form DNA (A-DNA)IBA 11/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2020
1	Hemoglobins (Hemoglobin)IBA 11/2020
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2020
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 11/2017
1	spebrutinibIBA 11/2017
1	Monoclonal AntibodiesIBA 03/2017
1	NVP-BKM120IBA 07/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2014
1	Apoptosis Regulatory ProteinsIBA 11/2013
1	Toll-Like Receptor 2IBA 11/2013
1	ChromatinIBA 11/2013
1	Immunoconjugates (Immunoconjugate)IBA 02/2013
1	GlucocorticoidsIBA 11/2012
1	RNA Splicing FactorsIBA 12/2011
1	Messenger RNA (mRNA)IBA 12/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2008
1	Histones (Histone)IBA 01/2008
1	DNA (Deoxyribonucleic Acid)IBA 01/2008
1	Etoposide (VP 16)FDA LinkGeneric 01/2008
1	ElementsIBA 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2002

Therapy/Procedure

16	Therapeutics 01/2024 - 02/2006
4	Drug Therapy (Chemotherapy) 10/2022 - 09/2013
3	Stem Cell Transplantation 05/2024 - 06/2006
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2021
2	Immunotherapy 01/2020 - 01/2020
1	Precision Medicine 09/2022
1	Plasma Exchange 11/2020
1	Splenectomy 11/2020
1	Salvage Therapy 09/2013
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2013
1	Aftercare (After-Treatment) 01/2008